Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07228039 · ClinicalTrials.gov registry record · Phase 4
ESP Blocks for Posterior Spinal Fusion
A Phase 4 study, sponsored by Duke University.
- Not yet
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
NCT07228039: Clinical Trial Phase 4 study, sponsored by Duke University.
NCT07228039 is a Phase 4 study that has not yet begun recruiting, run by Duke University. The registered enrollment target is 75 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07228039, a Phase 4 study, has not yet begun recruiting, sponsored by Duke University.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
Study Summary
This prospective randomized double-blind study evaluates the efficacy of erector spinae plane (ESP) blocks on postoperative pain in patients undergoing cervical or lumbar posterior spinal fusion. Patients will receive either 0.5% bupivacaine plus liposomal bupivacaine or 0.5% plain bupivacaine. Outcomes include opioid consumption over 72 hours, pain scores, length of stay, and time to ambulation.
Primary Outcome
Morphine MilliEquivalents
Interventions
- DRUG ESP Block with Bupivacaine
- DRUG ESP Block with Bupivacaine + Liposomal Bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2026-07 |
| Est. Completion | 2028-01 |
| Phase | Phase 4 |
What is known before NCT07228039 opens enrollment
NCT07228039 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which ESP Block with Bupivacaine is the first listed.
NCT07228039 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07228039 about?
NCT07228039 is a clinical study titled "ESP Blocks for Posterior Spinal Fusion". This prospective randomized double-blind study evaluates the efficacy of erector spinae plane (ESP) blocks on postoperative pain in patients undergoing cervical or lumbar posterior spinal fusion. Patients will receive either 0.5% bupivacaine plus liposomal bupivacaine or 0.5% plain bupivacaine. Outc...
What is the current status of trial NCT07228039?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2026-07. Estimated completion is 2028-01.
What interventions are being tested in trial NCT07228039?
The interventions under investigation include: ESP Block with Bupivacaine (DRUG), ESP Block with Bupivacaine + Liposomal Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT07228039?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07228039's enrollment target sits among peer trials
75 1002nd of 2000 higher than 974 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia